U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233850) titled 'A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers' on Nov. 14.
Brief Summary: This study is a multicenter, open-label, phase II clinical trial evaluating the combination of SSGJ-706 with standard therapy for advanced gastrointestinal tumors. Its objective is to assess the safety, tolerability, and antitumor activity of SSGJ-706 in combination with standard treatment.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Gastric/Gastroesophageal Junction Adenocarcinoma
Metastatic Colorectal Cancer (CRC)
Pancreatic Ductal Adenocarcinoma (PDAC)
Oesophageal Cancer...